α-Sulfoquinovosylmonoacylglycerol Is a Novel Potent Radiosensitizer Targeting Tumor Angiogenesis
Authors:
Open Access
- 15 February 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (4) , 2287-2295
Abstract
Angiogenesis is a promising target for the treatment of cancer, and varying types of antiangiogenic agents have been developed. However, limitations and problems associated with antiangiogenic therapy have recently arisen. Although radiotherapy can be combined with antiangiogenic compounds to overcome these difficulties, almost all previously described angiogenesis inhibitors could still cause side effects at effective doses, and only additive effects are seen in current combination therapy. In this study, we identified a member of the sulfoquinovosylacylglycerols, α-sulfoquinovosylmonoacylglycerol (α-SQMG), originally derived from sea urchins, as a potent radiosensitizer. The agent synergistically inhibits angiogenesis at low doses when combined with ionizing radiation. Combined treatment with α-SQMG and radiation seems to promote the adoption of a senescence-like phenotype by vascular endothelial cells. Finally, the agent remarkably enhances the radioresponse of human tumors transplanted into nude mice, accompanied by a significant reduction in the vascularity of the tumors. Collectively, α-SQMG may be a novel potent radiosensitizer targeting angiogenesis. (Cancer Res 2006; 66(4): 2287-95)Keywords
This publication has 24 references indexed in Scilit:
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Cancer without diseaseNature, 2004
- Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaksNature Cell Biology, 2004
- Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416Journal of Clinical Oncology, 2003
- Tumor Response to Radiotherapy Regulated by Endothelial Cell ApoptosisScience, 2003
- Redundancy of Radioresistant Signaling Pathways Originating from Insulin-like Growth Factor I ReceptorJournal of Biological Chemistry, 2003
- Anti‐tumor Effect of Chemically Synthesized Sulfolipids Based on Sea Urchin's Natural SulfonoquinovosylmonoacylglycerolsJapanese Journal of Cancer Research, 2002
- Structure‐Activity Relationship of a Novel Group of Mammalian DNA Polymerase Inhibitors, Synthetic SulfoquinovosylacylglycerolsJapanese Journal of Cancer Research, 2000
- Sulfoquinovosyldiacylglycerol, KM043, a New Potent Inhibitor of Eukaryotic DNA Polymerases and HIV-Reverse Transcriptase Type 1 from a Marine Red Alga, Gigartina tenella.Chemical and Pharmaceutical Bulletin, 1998
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994